The brain-immune-gut triangle: Innate immunity in psychiatric and neurological disorders

Current Immunology Reviews

Volumn 9, Issue 4, 2013, Pages 241-248

  Szabo, Attila ^a   Rajnavolgyi, Eva ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Gut microbiota; Gut brain axis; Innate immunity; Neuroimmunology; Pattern recognition receptors; Psychoneuroimmunology

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BACTEROIDES; BIFIDOBACTERIUM LONGUM; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; DENDRITIC CELL; EMBRYO DEVELOPMENT; GUT BRAIN IMMUNE TRIANGLE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE INNERVATION; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; MACROPHAGE; MENTAL DISEASE; MICROFLORA; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOPHYSIOLOGY; REVIEW; RUMINOCOCCUS; SCHIZOPHRENIA;

EID: 84900803034     PISSN: 15733955     EISSN: 1875631X     Source Type: Journal    
DOI: 10.2174/1573395509666131203225659     Document Type: Review

References (110)

1. Daruna JH. Introduction to Psychoneuroimmunology. Academic Press -Elsevier, 2012.
2. Daruna JH. Introduction to Psychoneuroimmunology. Academic Press -Elsevier, 2012.
3. Ader R. Historical perspective on psychoneuroimmunology. In: H. Friedman TWK, A.L. Friedman, editors. Psychoneuroimmunology, Stress, and Infection. CRC Press; 1995. p.
4. Besedovsky HO, Rey AD. Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun 2007; 21(1): 34-44.
5. Besedovsky HO, del Rey A and Sorkin E. Lymphokine-containing supernatants from con A-stimulated cells increase corticosterone blood levels. J Immunol 1981; 126(1): 385-7.
6. Crabtree GR, Gillis S, Smith KA and Munck A. Mechanisms of glucocorticoid-induced immunosuppression: inhibitory effects on expression of Fc receptors and production of T-cell growth factor. J Steroid Biochem 1980; 12: 445-9.
7. Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233(4764): 652-4.
8. Eskay RL, Grino M, Chen HT. Interleukins, signal transduction, and the immune system-mediated stress response. Adv Exp Med Biol 1990; 274: 331-43.
9. Lilly MP, Gann DS. The hypothalamic-pituitary-adrenal-immune axis. A critical assessment. Arch Surg 1992; 127(12): 1463-74.
10. Besedovsky HO, del Rey A, Klusman I, Furukawa H, Monge Arditi G, Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991; 40(4-6): 613-8.
11. Blalock JE, Smith EM. Conceptual development of the immune system as a sixth sense. Brain Behav Immun 2007; 21(1): 23-33.
12. Blalock JE, Harbour-McMenamin D, Smith EM. Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol 1985; 135(2 Suppl): 858s-861s.
13. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52(4): 595-638.
14. Sanders VM. Interdisciplinary research: noradrenergic regulation of adaptive immunity. Brain Behav Immun 2006; 20(1): 1-8.
15. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996; 17(1): 64-102.
16. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitaryadrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999; 79(1): 1-71.
17. Besedovsky HO, del Rey A. Regulating inflammation by glucocorticoids. Nat Immunol 2006; 7(6): 537.
18. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6(4): 318-28.
19. Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun 2007; 21(6): 727-35.
20. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10(11): 735-42.
21. Douglas-Escobar M, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 2013; 167(4): 374-9.
22. Chen X, D'Souza R, Hong ST. The role of gut microbiota in the gut-brain axis: current challenges and perspectives. Protein Cell 2013; 4(6): 403-14.
23. Forsythe P, Kunze WA, Bienenstock J. On communication between gut microbes and the brain. Curr Opin Gastroenterol 2012; 28(6): 557-62.
24. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013; 13(10): 722-37.
25. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 2012; 249(1): 158-75.
26. Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 2011; 11(3): 187-200.
27. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7(3): 179-190.
28. Dixit E, Kagan JC. Intracellular pathogen detection by RIG-I-like receptors. Adv Immunol 2013; 117: 99-125.
29. Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 2009; 9(7): 465-79.
30. Barbalat R, Ewald SE, Mouchess ML, Barton GM. Nucleic acid recognition by the innate immune system. Annu Rev Immunol 2011; 29: 185-214.
31. Brencicova E, Diebold SS. Nucleic acids and endosomal pattern recognition: how to tell friend from foe? Front Cell Infect Microbiol 2013; 3: 37.
32. Unterholzner L. The interferon response to intracellular DNA: Why so many receptors? Immunobiology 2013; 218(11): 1312-21.
33. Benko S, Magyarics Z, Szabo A, Rajnavolgyi E. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors. Biol Chem 2008; 389(5): 469-85.
34. Kaisho T, Akira S. Critical roles of Toll-like receptors in host defense. Crit Rev Immunol 2000; 20(5): 393-405.
35. Brown J, Wang H, Hajishengallis GN, Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and crosstalk. J Dent Res 2011; 90(4): 417-27.
36. Levitz SM. Innate recognition of fungal cell walls. PLoS Pathog 2010; 6(4): e1000758.
37. Geijtenbeek TB, van Vliet SJ, Engering A, Hart BA, van Kooyk Y. Self-and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 2004; 22: 33-54.
38. Szabo A, Bene K, Gogolak P, et al. RLR-mediated production of interferon-beta by a human dendritic cell subset and its role in virus-specific immunity. J Leukoc Biol 2012; 92: (1) 159-69.
39. Rock KL, Lai JJ, Kono H. Innate and adaptive immune responses to cell death. Immunol Rev 2011; 243(1): 191-205.
40. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008; 8(11): 837-48.
41. Sun SC, Chang JH, Jin J. Regulation of nuclear factor-kappaB in autoimmunity. Trends Immunol 2013; 34(6): 282-9.
42. Doria A, Dayer JM, Punzi L. Autoinflammatory diseases: how to put the fire inside the body out? Autoimmun Rev 2012; 12(1): 1-4.
43. Doria A, Zen M, Bettio S, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 2012; 12(1): 22-30.
44. Hampel H, Lista S. Alzheimer disease: From inherited to sporadic AD-crossing the biomarker bridge. Nat Rev Neurol 2012; 8(11): 598-600.
45. Bettens K, Sleegers K, Van Broeckhoven C. Genetic insights in Alzheimer's disease. Lancet Neurol 2013; 12(1): 92-104.
46. Krstic D, Knuesel I. Deciphering the mechanism underlying lateonset Alzheimer disease. Nat Rev Neurol 2013; 9(1): 25-34.
47. Sardi F, Fassina L, Venturini L, Inguscio M, Guerriero F, Rolfo E, Ricevuti G. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun Rev 2011; 11(2): 149-53.
48. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41(10): 1088-1093.
49. Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41(10): 1094-9.
50. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 2010; 68(10): 930-41.
51. Cribbs DH, Berchtold NC, Perreau V, et al. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 2012; 9: 179.
52. Meyer U, Nyffeler M, Engler A, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006; 26(18): 4752-62.
53. Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 2008; 33(2): 441-56.
54. Krstic D, Madhusudan A, Doehner J, et al. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation 2012; 9: 151.
55. Heneka MT, Kummer MP, Stutz A, et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013; 493(7434): 674-8.
56. Holmes C, Cunningham C, Zotova E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009; 73(10): 768-74.
57. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9(1): 46-56.
58. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27(1): 24-31.
59. Jones KA, Thomsen C. The role of the innate immune system in psychiatric disorders. Mol Cell Neurosci 2013; 53: 52-62.
60. Barrientos RM, Sprunger DB, Campeau S, Watkins LR, Rudy JW, Maier SF. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration. J Neuroimmunol 2004; 155(1-2): 119-26.
61. Meyer U, Feldon J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 2012; 62(3): 1308-21.
62. Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ. Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 2013; 28: 170-81.
63. Anisman H, Poulter MO, Gandhi R, Merali Z, Hayley S. Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations. J Neuroimmunol 2007; 186(1-2): 45-53.
64. Pavol MA, Meyers CA, Rexer JL, Valentine AD, Mattis PJ, Talpaz M. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 1995; 45(5): 947-50.
65. Halaris A. Comorbidity between depression and cardiovascular disease. Int Angiol 2009; 28(2): 92-9.
66. Johnson AK, Grippo AJ. Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 2006; 57 Suppl 11: 5-29.
67. Dinan TG. Inflammatory markers in depression. Curr Opin Psychiatry 2009; 22(1): 32-6.
68. Hernandez ME, Mendieta D, Martinez-Fong D, et al. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. Eur Neuropsychopharmacol 2008; 18(12): 917-24.
69. Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 2009; 70(8): 1078-90.
70. Soderlund J, Olsson SK, Samuelsson M, et al. Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder. J Psychiatry Neurosci 2011; 36(2): 114-8.
71. Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, et al. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J europsychopharmacol 2010; 13(10): 1369-81.
72. Suvisaari J, Mantere O. Inflammation theories in psychotic disorders: a critical review. Infect Disord Drug Targets 2013; 13(1): 59-70.
73. Venkatasubramanian G, Debnath M. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 44: 301-11.
74. Yoshimi N, Futamura T, Hashimoto K. Prenatal immune activation and subsequent peripubertal stress as a new model of schizophrenia. Expert Rev Neurother 2013; 13(7): 747-50.
75. Canetta SE, Brown AS. Prenatal Infection, Maternal Immune Activation, and Risk for Schizophrenia. Transl Neurosci 2012; 3(4): 320-7.
76. Kang WS, Park JK, Lee SM, Kim SK, Park HJ, Kim JW. Association between genetic polymorphisms of Toll-like receptor 2 (TLR2) and schizophrenia in the Korean population. Gene 2013; 526(2): 182-6.
77. Li Y, Zhou K, Zhang Z, et al. Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia. Mol Biosyst 2012; 8(10): 2664-71.
78. Muller N, Wagner JK, Krause D, et al. Impaired monocyte activation in schizophrenia. Psychiatry Res 2012; 198(3): 341-6.
79. Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, Yamauchi Y, Yamada S, Kanba S. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 42: 115-21.
80. Drexhage RC, Weigelt K, van Beveren N, et al. Immune and neuroimmune alterations in mood disorders and schizophrenia. Int Rev Neurobiol 2011; 101: 169-201.
81. Irwin MR, Levin MJ, Carrillo C, et al. Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun 2011; 25(4): 759-66.
82. Garate I, Garcia-Bueno B, Madrigal JL, et al. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation 2011; 8: 151.
83. Garate I, Garcia-Bueno B, Madrigal JL, Caso JR, Alou L, Gomez-Lus ML, Mico JA, Leza JC. Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol Psychiatry 2013; 73(1): 32-43.
84. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011; 473(7346): 174-180.
85. Amaral FA, Sachs D, Costa VV, et al. Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci USA 2008; 105(6): 2193-7.
86. Dumas ME, Barton RH, Toye A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulinresistant mice. Proc Natl Acad Sci USA 2006; 103(33): 12511-6.
87. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013; 36(5): 305-12.
88. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012; 13(10): 701-12.
89. Al-Asmakh M, Anuar F, Zadjali F, Rafter J, Pettersson S. Gut microbial communities modulating brain development and function. Gut Microbes 2012; 3(4): 366-73.
90. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxietylike behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23(3): 255-64, e119.
91. Morgan MY, Blei A, Grungreiff K, et al. The treatment of hepatic encephalopathy. Metab Brain Dis 2007; 22(3-4): 389-405.
92. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther 2003; 10(1): 61-7.
93. Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 2006; 89(3): 350-7.
94. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558(Pt 1): 263-75.
95. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008; 43(2): 164-74.
96. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011; 105(5): 755-64.
97. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011; 108(38): 16050-5.
98. Bercik P, Park AJ, Sinclair D, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011; 23(12): 1132-9.
99. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141(2): 599-609.
100. Diaz Heijtz R, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108(7): 3047-52.
101. Tannock GW, Savage DC. Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect Immun 1974; 9(3): 591-8.
102. Bailey MT, Coe CL. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol 1999; 35(2): 146-55.
103. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479(7374): 538-41.
104. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170(4): 1179-88.
105. Kim HR, Jung KY, Kim SY, Ko KO, Lee YM, Kim JM. Delivery modes and neonatal EEG: spatial pattern analysis. Early Hum Dev 2003; 75(1-2): 35-53.
106. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011; 12(8): 453-66.
107. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22(5): 512-9.
108. Ledochowski M, Widner B, Sperner-Unterweger B, Propst T, Vogel W, Fuchs D. Carbohydrate malabsorption syndromes and early signs of mental depression in females. Dig Dis Sci 2000; 45(7): 1255-9.
109. Myint AM. Kynurenines: from the perspective of major psychiatric disorders. FEBS J 2012; 279(8): 1375-85.
110. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113(2): 411-7.